| __timestamp | Amgen Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 4699000000 | 5078000000 |
| Thursday, January 1, 2015 | 4846000000 | 4717000000 |
| Friday, January 1, 2016 | 5062000000 | 5096000000 |
| Sunday, January 1, 2017 | 4870000000 | 4986000000 |
| Monday, January 1, 2018 | 5332000000 | 4214000000 |
| Tuesday, January 1, 2019 | 5150000000 | 3806000000 |
| Wednesday, January 1, 2020 | 5730000000 | 3671000000 |
| Friday, January 1, 2021 | 5368000000 | 3528000000 |
| Saturday, January 1, 2022 | 5414000000 | 3445000000 |
| Sunday, January 1, 2023 | 6179000000 | 3498000000 |
| Monday, January 1, 2024 | 7096000000 | 3702000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, effective cost management is crucial for maintaining competitive advantage. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Amgen Inc. and Teva Pharmaceutical Industries Limited from 2014 to 2023. Over this period, Amgen's SG&A expenses have shown a steady upward trend, increasing by approximately 31% from 2014 to 2023. In contrast, Teva's expenses have decreased by about 31%, reflecting strategic cost-cutting measures.
Amgen's peak in 2023, with expenses reaching $6.18 billion, underscores its investment in growth and innovation. Meanwhile, Teva's reduction to $3.50 billion highlights its focus on efficiency amidst industry challenges. These contrasting strategies offer valuable insights into how leading pharmaceutical companies manage costs in a dynamic market landscape.
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Amgen Inc.
Who Optimizes SG&A Costs Better? Amgen Inc. or Walgreens Boots Alliance, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Exelixis, Inc.
Comparing SG&A Expenses: Amgen Inc. vs TG Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Amgen Inc. vs Viking Therapeutics, Inc.
Breaking Down SG&A Expenses: Amgen Inc. vs Merus N.V.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Amgen Inc. and Agios Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Sanofi or Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited and Viatris Inc.: SG&A Spending Patterns Compared
Teva Pharmaceutical Industries Limited and Verona Pharma plc: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Vericel Corporation